Identification and Analysis of P53-Mediated Competing Endogenous RNA Network in Human Hepatocellular Carcinoma

Recent studies have indicated that long non-coding RNAs (lncRNAs) and mRNA function as competing endogenous RNAs (ceRNAs) that compete to bind to shared microRNA (miRNA) recognition elements (MREs) to perform specific biological functions during tumorigenesis. The tumor suppressor p53 is a master re...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of biological sciences 2017-01, Vol.13 (9), p.1213-1221
Hauptverfasser: Zhang, Yiming, Kang, Ran, Liu, Wenrong, Yang, Yalan, Ding, Ruofan, Huang, Qingqing, Meng, Junhua, Xiong, Lili, Guo, Zhiyun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1221
container_issue 9
container_start_page 1213
container_title International journal of biological sciences
container_volume 13
creator Zhang, Yiming
Kang, Ran
Liu, Wenrong
Yang, Yalan
Ding, Ruofan
Huang, Qingqing
Meng, Junhua
Xiong, Lili
Guo, Zhiyun
description Recent studies have indicated that long non-coding RNAs (lncRNAs) and mRNA function as competing endogenous RNAs (ceRNAs) that compete to bind to shared microRNA (miRNA) recognition elements (MREs) to perform specific biological functions during tumorigenesis. The tumor suppressor p53 is a master regulator of cancer-related biological processes by acting as a transcription factor to regulate target genes including miRNA and lncRNA. However, the mechanism in human hepatocellular carcinoma and whether p53-mediated RNA targets could form ceRNA network remain unclear. Here, we identified a series of differential expressed miRNAs, lncRNA and mRNA which were potentially regulated by p53 using RNA sequencing in HepG2. Genomic characteristics comparative analysis showed significant differences between mRNAs and lncRNAs. By integrating experimentally confirmed Ago2 and p53 binding sites, we constructed a highly reliable p53-mediated ceRNA network using hypergeometric test. The KEGG pathway enrichment analysis showed that the ceRNA network highly enriched in the cancer or p53-associated signaling pathways. Finally, using betweenness centrality analysis, we identified five master miRNAs (hsa-miR-3620-5p, hsa-miR-3613-3p, hsa-miR-6881-3p, hsa-miR-6087 and hsa-miR-18a-3p) that regulated most of the target RNAs, suggesting these miRNAs play central roles in the whole p53-mediated ceRNAs network. Taken together, our results provide a new regulatory mechanism of p53 networks for future studies in cancer therapeutics.
doi_str_mv 10.7150/ijbs.21502
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5666336</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1984768140</sourcerecordid><originalsourceid>FETCH-LOGICAL-c406t-d89304c7e23531bcb25d044c67b87620797b488fba0aded5dfa05f0ee1fc1e053</originalsourceid><addsrcrecordid>eNpdkV9r1UAQxYMotlZf_ACy4IsIqbN_s3kRLpdqC7WK6POy2Z1c95rsXncTpd_exNZSfZkZmB-HOXOq6jmF04ZKeBP2XTlly8QeVMdUiLZmTOuH9-aj6kkpewCupIbH1RFrKQhJ2XEVLzzGKfTB2SmkSGz0ZBPtcF1CIaknnySvP6APdkJPtmk84BTijpxFn3YY01zI56sNucLpV8rfSYjkfB7tUvFgp-RwGObBZrK12YWYRvu0etTboeCz235SfX139mV7Xl9-fH-x3VzWToCaaq9bDsI1yLjktHMdkx6EcKrpdKMYNG3TCa37zoL16KXvLcgeEGnvKILkJ9XbG93D3I3o3eIx28EcchhtvjbJBvPvJoZvZpd-GqmU4lwtAq9uBXL6MWOZzBjK6sdGXFwb2ioKXICGBX35H7pPc15-uFJaNEpTsVKvbyiXUykZ-7tjKJg1RrPGaP7EuMAv7p9_h_7Njf8GWXeZww</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1984768140</pqid></control><display><type>article</type><title>Identification and Analysis of P53-Mediated Competing Endogenous RNA Network in Human Hepatocellular Carcinoma</title><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Zhang, Yiming ; Kang, Ran ; Liu, Wenrong ; Yang, Yalan ; Ding, Ruofan ; Huang, Qingqing ; Meng, Junhua ; Xiong, Lili ; Guo, Zhiyun</creator><creatorcontrib>Zhang, Yiming ; Kang, Ran ; Liu, Wenrong ; Yang, Yalan ; Ding, Ruofan ; Huang, Qingqing ; Meng, Junhua ; Xiong, Lili ; Guo, Zhiyun</creatorcontrib><description>Recent studies have indicated that long non-coding RNAs (lncRNAs) and mRNA function as competing endogenous RNAs (ceRNAs) that compete to bind to shared microRNA (miRNA) recognition elements (MREs) to perform specific biological functions during tumorigenesis. The tumor suppressor p53 is a master regulator of cancer-related biological processes by acting as a transcription factor to regulate target genes including miRNA and lncRNA. However, the mechanism in human hepatocellular carcinoma and whether p53-mediated RNA targets could form ceRNA network remain unclear. Here, we identified a series of differential expressed miRNAs, lncRNA and mRNA which were potentially regulated by p53 using RNA sequencing in HepG2. Genomic characteristics comparative analysis showed significant differences between mRNAs and lncRNAs. By integrating experimentally confirmed Ago2 and p53 binding sites, we constructed a highly reliable p53-mediated ceRNA network using hypergeometric test. The KEGG pathway enrichment analysis showed that the ceRNA network highly enriched in the cancer or p53-associated signaling pathways. Finally, using betweenness centrality analysis, we identified five master miRNAs (hsa-miR-3620-5p, hsa-miR-3613-3p, hsa-miR-6881-3p, hsa-miR-6087 and hsa-miR-18a-3p) that regulated most of the target RNAs, suggesting these miRNAs play central roles in the whole p53-mediated ceRNAs network. Taken together, our results provide a new regulatory mechanism of p53 networks for future studies in cancer therapeutics.</description><identifier>ISSN: 1449-2288</identifier><identifier>EISSN: 1449-2288</identifier><identifier>DOI: 10.7150/ijbs.21502</identifier><identifier>PMID: 29104512</identifier><language>eng</language><publisher>Australia: Ivyspring International Publisher Pty Ltd</publisher><subject>Argonaute 2 protein ; Binding sites ; Biological activity ; Cancer ; Comparative analysis ; Construction sites ; Gene sequencing ; Hepatocellular carcinoma ; Liver cancer ; miRNA ; p53 Protein ; Regulatory mechanisms (biology) ; Research Paper ; Ribonucleic acid ; RNA ; Signaling ; Tumor suppressor genes ; Tumorigenesis</subject><ispartof>International journal of biological sciences, 2017-01, Vol.13 (9), p.1213-1221</ispartof><rights>Copyright BioMed Central 2017</rights><rights>Ivyspring International Publisher 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c406t-d89304c7e23531bcb25d044c67b87620797b488fba0aded5dfa05f0ee1fc1e053</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666336/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666336/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29104512$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Yiming</creatorcontrib><creatorcontrib>Kang, Ran</creatorcontrib><creatorcontrib>Liu, Wenrong</creatorcontrib><creatorcontrib>Yang, Yalan</creatorcontrib><creatorcontrib>Ding, Ruofan</creatorcontrib><creatorcontrib>Huang, Qingqing</creatorcontrib><creatorcontrib>Meng, Junhua</creatorcontrib><creatorcontrib>Xiong, Lili</creatorcontrib><creatorcontrib>Guo, Zhiyun</creatorcontrib><title>Identification and Analysis of P53-Mediated Competing Endogenous RNA Network in Human Hepatocellular Carcinoma</title><title>International journal of biological sciences</title><addtitle>Int J Biol Sci</addtitle><description>Recent studies have indicated that long non-coding RNAs (lncRNAs) and mRNA function as competing endogenous RNAs (ceRNAs) that compete to bind to shared microRNA (miRNA) recognition elements (MREs) to perform specific biological functions during tumorigenesis. The tumor suppressor p53 is a master regulator of cancer-related biological processes by acting as a transcription factor to regulate target genes including miRNA and lncRNA. However, the mechanism in human hepatocellular carcinoma and whether p53-mediated RNA targets could form ceRNA network remain unclear. Here, we identified a series of differential expressed miRNAs, lncRNA and mRNA which were potentially regulated by p53 using RNA sequencing in HepG2. Genomic characteristics comparative analysis showed significant differences between mRNAs and lncRNAs. By integrating experimentally confirmed Ago2 and p53 binding sites, we constructed a highly reliable p53-mediated ceRNA network using hypergeometric test. The KEGG pathway enrichment analysis showed that the ceRNA network highly enriched in the cancer or p53-associated signaling pathways. Finally, using betweenness centrality analysis, we identified five master miRNAs (hsa-miR-3620-5p, hsa-miR-3613-3p, hsa-miR-6881-3p, hsa-miR-6087 and hsa-miR-18a-3p) that regulated most of the target RNAs, suggesting these miRNAs play central roles in the whole p53-mediated ceRNAs network. Taken together, our results provide a new regulatory mechanism of p53 networks for future studies in cancer therapeutics.</description><subject>Argonaute 2 protein</subject><subject>Binding sites</subject><subject>Biological activity</subject><subject>Cancer</subject><subject>Comparative analysis</subject><subject>Construction sites</subject><subject>Gene sequencing</subject><subject>Hepatocellular carcinoma</subject><subject>Liver cancer</subject><subject>miRNA</subject><subject>p53 Protein</subject><subject>Regulatory mechanisms (biology)</subject><subject>Research Paper</subject><subject>Ribonucleic acid</subject><subject>RNA</subject><subject>Signaling</subject><subject>Tumor suppressor genes</subject><subject>Tumorigenesis</subject><issn>1449-2288</issn><issn>1449-2288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpdkV9r1UAQxYMotlZf_ACy4IsIqbN_s3kRLpdqC7WK6POy2Z1c95rsXncTpd_exNZSfZkZmB-HOXOq6jmF04ZKeBP2XTlly8QeVMdUiLZmTOuH9-aj6kkpewCupIbH1RFrKQhJ2XEVLzzGKfTB2SmkSGz0ZBPtcF1CIaknnySvP6APdkJPtmk84BTijpxFn3YY01zI56sNucLpV8rfSYjkfB7tUvFgp-RwGObBZrK12YWYRvu0etTboeCz235SfX139mV7Xl9-fH-x3VzWToCaaq9bDsI1yLjktHMdkx6EcKrpdKMYNG3TCa37zoL16KXvLcgeEGnvKILkJ9XbG93D3I3o3eIx28EcchhtvjbJBvPvJoZvZpd-GqmU4lwtAq9uBXL6MWOZzBjK6sdGXFwb2ioKXICGBX35H7pPc15-uFJaNEpTsVKvbyiXUykZ-7tjKJg1RrPGaP7EuMAv7p9_h_7Njf8GWXeZww</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Zhang, Yiming</creator><creator>Kang, Ran</creator><creator>Liu, Wenrong</creator><creator>Yang, Yalan</creator><creator>Ding, Ruofan</creator><creator>Huang, Qingqing</creator><creator>Meng, Junhua</creator><creator>Xiong, Lili</creator><creator>Guo, Zhiyun</creator><general>Ivyspring International Publisher Pty Ltd</general><general>Ivyspring International Publisher</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170101</creationdate><title>Identification and Analysis of P53-Mediated Competing Endogenous RNA Network in Human Hepatocellular Carcinoma</title><author>Zhang, Yiming ; Kang, Ran ; Liu, Wenrong ; Yang, Yalan ; Ding, Ruofan ; Huang, Qingqing ; Meng, Junhua ; Xiong, Lili ; Guo, Zhiyun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c406t-d89304c7e23531bcb25d044c67b87620797b488fba0aded5dfa05f0ee1fc1e053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Argonaute 2 protein</topic><topic>Binding sites</topic><topic>Biological activity</topic><topic>Cancer</topic><topic>Comparative analysis</topic><topic>Construction sites</topic><topic>Gene sequencing</topic><topic>Hepatocellular carcinoma</topic><topic>Liver cancer</topic><topic>miRNA</topic><topic>p53 Protein</topic><topic>Regulatory mechanisms (biology)</topic><topic>Research Paper</topic><topic>Ribonucleic acid</topic><topic>RNA</topic><topic>Signaling</topic><topic>Tumor suppressor genes</topic><topic>Tumorigenesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Yiming</creatorcontrib><creatorcontrib>Kang, Ran</creatorcontrib><creatorcontrib>Liu, Wenrong</creatorcontrib><creatorcontrib>Yang, Yalan</creatorcontrib><creatorcontrib>Ding, Ruofan</creatorcontrib><creatorcontrib>Huang, Qingqing</creatorcontrib><creatorcontrib>Meng, Junhua</creatorcontrib><creatorcontrib>Xiong, Lili</creatorcontrib><creatorcontrib>Guo, Zhiyun</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of biological sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Yiming</au><au>Kang, Ran</au><au>Liu, Wenrong</au><au>Yang, Yalan</au><au>Ding, Ruofan</au><au>Huang, Qingqing</au><au>Meng, Junhua</au><au>Xiong, Lili</au><au>Guo, Zhiyun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification and Analysis of P53-Mediated Competing Endogenous RNA Network in Human Hepatocellular Carcinoma</atitle><jtitle>International journal of biological sciences</jtitle><addtitle>Int J Biol Sci</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>13</volume><issue>9</issue><spage>1213</spage><epage>1221</epage><pages>1213-1221</pages><issn>1449-2288</issn><eissn>1449-2288</eissn><abstract>Recent studies have indicated that long non-coding RNAs (lncRNAs) and mRNA function as competing endogenous RNAs (ceRNAs) that compete to bind to shared microRNA (miRNA) recognition elements (MREs) to perform specific biological functions during tumorigenesis. The tumor suppressor p53 is a master regulator of cancer-related biological processes by acting as a transcription factor to regulate target genes including miRNA and lncRNA. However, the mechanism in human hepatocellular carcinoma and whether p53-mediated RNA targets could form ceRNA network remain unclear. Here, we identified a series of differential expressed miRNAs, lncRNA and mRNA which were potentially regulated by p53 using RNA sequencing in HepG2. Genomic characteristics comparative analysis showed significant differences between mRNAs and lncRNAs. By integrating experimentally confirmed Ago2 and p53 binding sites, we constructed a highly reliable p53-mediated ceRNA network using hypergeometric test. The KEGG pathway enrichment analysis showed that the ceRNA network highly enriched in the cancer or p53-associated signaling pathways. Finally, using betweenness centrality analysis, we identified five master miRNAs (hsa-miR-3620-5p, hsa-miR-3613-3p, hsa-miR-6881-3p, hsa-miR-6087 and hsa-miR-18a-3p) that regulated most of the target RNAs, suggesting these miRNAs play central roles in the whole p53-mediated ceRNAs network. Taken together, our results provide a new regulatory mechanism of p53 networks for future studies in cancer therapeutics.</abstract><cop>Australia</cop><pub>Ivyspring International Publisher Pty Ltd</pub><pmid>29104512</pmid><doi>10.7150/ijbs.21502</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1449-2288
ispartof International journal of biological sciences, 2017-01, Vol.13 (9), p.1213-1221
issn 1449-2288
1449-2288
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5666336
source PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Argonaute 2 protein
Binding sites
Biological activity
Cancer
Comparative analysis
Construction sites
Gene sequencing
Hepatocellular carcinoma
Liver cancer
miRNA
p53 Protein
Regulatory mechanisms (biology)
Research Paper
Ribonucleic acid
RNA
Signaling
Tumor suppressor genes
Tumorigenesis
title Identification and Analysis of P53-Mediated Competing Endogenous RNA Network in Human Hepatocellular Carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T08%3A32%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20and%20Analysis%20of%20P53-Mediated%20Competing%20Endogenous%20RNA%20Network%20in%20Human%20Hepatocellular%20Carcinoma&rft.jtitle=International%20journal%20of%20biological%20sciences&rft.au=Zhang,%20Yiming&rft.date=2017-01-01&rft.volume=13&rft.issue=9&rft.spage=1213&rft.epage=1221&rft.pages=1213-1221&rft.issn=1449-2288&rft.eissn=1449-2288&rft_id=info:doi/10.7150/ijbs.21502&rft_dat=%3Cproquest_pubme%3E1984768140%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1984768140&rft_id=info:pmid/29104512&rfr_iscdi=true